Corporate Banner
Satellite Banner
Biologics & Bioprocessing
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

The Conference Forum Announces the Launch of the 2nd Annual Medicaid Rebate Summit

Published: Wednesday, October 30, 2013
Last Updated: Wednesday, October 30, 2013
Bookmark and Share
Summit will address the interpretation of the anticipated Final Rule and the larger implications of Medicaid expansion.

In anticipation of the Final Rule and Medicaid expansion, the Conference Forum announced the launch of the 2nd annual Medicaid Rebate Summit for January 22-23 in Washington DC. The MRS Summit helps pharmaceutical, biotech and generic drug manufacturers along with states and pharmacy leaders to navigate the complexities of the Medicaid Rebate process.

Co-Chair, Jim Abrams, Director, Government Pricing & Reporting, Mylan Pharmaceuticals, noted "The Summit's agenda is timely and includes topics that will benefit all Government Pricing staffers and Pharma professionals who are impacted by developments in government pricing programs."

Program Co-Chair, Stephanie Kupski, Sr. Director Managed Markets & HCP Compliance, Iroko Pharmaceuticals LLC, added, "With the GP community eagerly awaiting the release of the final AMP rule in January, the Medicaid Rebate Summit couldn’t be more relevant. I look forward to discussing implementation strategies with my colleagues.”

“The need to bring together CMS, manufacturers, states, pharmacy leaders and other key stakeholders to work through the many changes affecting the MDRP is so crucial that we moved the event up a month to January,” explains Valerie Bowling, Executive Director of the Conference Forum.

The 2014 Keynote is Adam J. Fein, PhD, President, Pembroke Consulting and Author, Drug Channels. Dr Fein was chosen as the 2014 Keynote for being the most recommended speaker by manufacturers for his insights into pharmaceutical economics and the impact on Medicaid Drug Rebates. 2013 Keynote, Alice Valder Curran of Hogan Lovells is back to help demystify the interpretation of the Final Rule.


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,400+ scientific posters on ePosters
  • More than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

The Conference Forum Announces the Launch of the 2nd Annual Medicaid Rebate Summit
Summit will address the interpretation of the anticipated Final Rule and the larger implications of Medicaid expansion.
Wednesday, November 13, 2013
Scientific News
First Artificial Ribosome Designed
Researchers at the University of Illinois at Chicago and Northwestern University have engineered a tethered ribosome that works nearly as well as the authentic cellular component, or organelle, that produces all the proteins and enzymes within the cell.
Experimental MERS Vaccine Shows Promise in Animal Studies
A two-step regimen of experimental vaccines against Middle East respiratory syndrome (MERS) prompted immune responses in mice and rhesus macaques, report National Institutes of Health scientists who designed the vaccines.
Sweet Revenge Against Superbugs
A special type of synthetic sugar could be the latest weapon in the fight against superbugs.
Researchers Develop Vaccine that Protects Primates Against Ebola
A collaborative team from The University of Texas Medical Branch at Galveston and the National Institutes of Health have developed an inhalable vaccine that protects primates against Ebola.
Universal Flu Vaccine in the Works
A new study has demonstrated a potential strategy for developing a flu vaccine with potent, broad protection.
Immunotherapy Shows Promise for Myeloma
A strategy, which uses patients’ own immune cells, genetically engineered to target tumors, has shown significant success against multiple myeloma, a cancer of the plasma cells that is largely incurable.
Ferring Bets on Bacteriophages to Treat Inflammatory Bowel Disease
Ferring Pharmaceuticals have annoucned that it will collaborate with Intralytix in the latest phase of its early stage development programme for a bacteriophage-based therapy for inflammatory bowel disease (IBD).
A Novel Drug to FIght Malaria
An international team of scientists has announced that a new compound to fight malaria is ready for human trials.
Ebola Vaccine Trial Begins in Senegal
A clinical trial to evaluate an Ebola vaccine has begun in Dakar, Senegal, after initial research started at the Jenner Institute, Oxford University.
New Cell Structure Finding Might Lead to Novel Cancer Therapies
University of Warwick scientists in the U.K. say they have discovered a cell structure which could help researchers understand why some cancers develop.
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,400+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!